Skip to main content
  • 81 Accesses

Abstract

Hyperinsulinaemia arises spontaneously under many different circumstances and can be induced experimentally by a variety of means. The consequences of hyperinsulinaemia are complex and depend to some extent on its aetiology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fajans SS & Floyd JC Jr.: Diagnosis and management of insulinomas. Ann. Rev. Med. 30: 313, 1979.

    Article  PubMed  CAS  Google Scholar 

  2. Schimke RN: Syndromes with multiple endocrine gland involvement. Prog. Med. Genet. 3: 143, 1979.

    PubMed  CAS  Google Scholar 

  3. Scarlett JA, Kolterman OG, Moore P, Saekow M, Insel J, Griffin J, Mako M, Rubenstein AH & Olefsky JM: Insulin resistance and diabetes due to a genetic defect in insulin receptors. J. Clin. Endocrinol. Metab. 55: 123, 1982.

    Article  PubMed  CAS  Google Scholar 

  4. Flier JS, Kahn CR, Roth J & Bar RS: Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 190: 63, 1975.

    Article  PubMed  CAS  Google Scholar 

  5. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, & Roth J: The syndromes of insulin resistance and acanthosis nigricans-insulin-receptor disorders in man. N. Engl. J. Med. 294: 739, 1976.

    Article  PubMed  CAS  Google Scholar 

  6. Olefsky J, Reaven GM & Farquhar JW: Effects of weight reduction on obesity. J. Clin. Invest. 53: 64, 1974.

    Google Scholar 

  7. Caro JF & Amatruda JM: Glucocorticoid-induced insulin resistance. J. Clin. Invest. 69: 866, 1982.

    Article  PubMed  CAS  Google Scholar 

  8. Trimble ER, Atkinson AB, Buchanan KD & Hadden DR: Plasma glucagon and insulin concentrations in acromegaly. J. Clin. Endocrinol. Metab. 51: 626, 1980.

    Article  PubMed  CAS  Google Scholar 

  9. Kobayashi M, Olefsky JM, Elders J, Mako ME, Given BD, Schedwie HK, Fiser RH, Hintz RL, Horner JA & Rubenstein A: Insulin resistance due to a defect distal to the insulin receptor: demonstration in a patient with leprechaunism. Proc. Natl. Acad. Sci. (USA) 75: 3469, 1978.

    Article  CAS  Google Scholar 

  10. Kobayashi M, Meek JC & Streib E: The insulin receptor in myotonic dystrophy. J. Clin. Endocrinol. Metab. 45: 821, 1977.

    Article  PubMed  CAS  Google Scholar 

  11. Duckworth WC, Solomon SS, Jallepalli P, Heckemeyer C, Finnern J & Powers A: Glucose intolerance due to insulin resistance in patients with spinal cord injuries. Diabetes 29: 906, 1980.

    Article  PubMed  CAS  Google Scholar 

  12. Le Marchand-Brustel Y, Freychet P & Jeanrenaud B: Longitudinal study on the establishment of insulin resistance in hypothalamic obese mice. Endocrinology 102: 74, 1978.

    Article  Google Scholar 

  13. Ferrannini E, Wahren J, Faber OK, Felig P, Binder C & DeFronzo RA: Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am. J. Physiol. 244: E517, 1983.

    PubMed  CAS  Google Scholar 

  14. Rabkin R, Ryan MP & Duckworth WC: The renal metabolism of insulin. Diabetologia 27: 351, 1984.

    Article  PubMed  CAS  Google Scholar 

  15. Maloff BL, McCaleb ML & Lockwood DH: Cellular basis of insulin resistance in chronic uremia. Am. J. Physiol. 245: E178, 1983.

    PubMed  CAS  Google Scholar 

  16. Kauffman JM & Caro JF: Insulin resistance in uremia. Characterization of insulin action, binding and processing in isolated hepatocytes from chronic uremic rats. J. Clin. Invest. 71: 698, 1983.

    Article  PubMed  CAS  Google Scholar 

  17. Gabbay KH, De Luca K, Fischer JN Jr., Mako ME & Rubenstein AH: Familial proinsulinemia: an autosomal dominant defect. N. Engl. J. Med. 294: 911, 1976.

    Article  PubMed  CAS  Google Scholar 

  18. Robbins DC, Blix PM, Rubenstein AH, Kanazawa Y, Kosaka K & Tager HS: A human proinsulin variant at arginine 65. Nature 291: 679, 1981.

    Article  PubMed  CAS  Google Scholar 

  19. Tager H, Given B, Baldwin D, Mako M, Markese J, Rubenstein A, Olefsky J, Kobayashi M, Kolterman O & Poucher R: A structurally abnormal insulin causing human diabetes. Nature 281: 122, 1979.

    Article  PubMed  CAS  Google Scholar 

  20. Olefsky JM, Saekow M, Tager H & Rubenstein AH: Characterization of a mutant human insulin species. J. Biol. Chem. 255: 6098, 1980.

    PubMed  CAS  Google Scholar 

  21. Couropmitree C, Freinkel N,. Nagel TC, Horwitz DL, Metzger BE, Rubenstein AH & Hahnel R; Plasma C-peptide and diagnosis of factitious hyperinsulinism. Ann. Intern. Med. 82: 201, 1975.

    PubMed  CAS  Google Scholar 

  22. Felig P, Marliss EB & Cahill GF Jr.: Plasma amino acid levels and insulin secretion in obesity. N. Engl. J. Med. 281: 811, 1969.

    Article  PubMed  CAS  Google Scholar 

  23. Amatruda JM, Newmeyer HW & Chang CL: Insulin-induced alterations in insulin binding and insulin action in primary cultures of rat hepatocytes. Diabetes 31: 145, 1982.

    Article  PubMed  CAS  Google Scholar 

  24. Harano Y, Ohgaku S, Kosugi K, Yasuda H, Nakano T, Kobayashi M, Hidaka H, Izumi K, Kashiwagi A, Shigeta Y: Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin and somatostatin infusion. J. Clin. Endocrinol. Metab. 52: 982, 1981.

    Article  PubMed  CAS  Google Scholar 

  25. De Fronzo RA, Hendler R & Simonson D: Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes 31: 795, 1982.

    Google Scholar 

  26. Pernet A, Trimble ER, Kuntschen F, Damoiseaux P, Assal J.-Ph., Hahn C & Renold AE: Insulin resistance in type I (insulin-dependent) diabetes: dependence on plasma insulin concentration. Diabetologia 26: 255, 1984.

    Article  PubMed  CAS  Google Scholar 

  27. Yki-Järvinen H & Koivisto VA: Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type I diabetes. J. Clin. Endocrinol. Metab. 58: 659, 1984.

    Article  PubMed  Google Scholar 

  28. Revers RR, Kolterman OG, Scarlett JA, Gray RS & Olefsky JM: Lack of in vivo insulin resistance in controlled insulin-dependent, type I, diabetic patients. J. Clin. Endocrinol. Metab. 58: 353, 1984.

    Article  PubMed  CAS  Google Scholar 

  29. Sacca L, Sherwin R, Hendler R & Felig P: Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. J. Clin. Invest. 63: 849, 1979.

    Article  PubMed  CAS  Google Scholar 

  30. Proietto J, Nankervis A, Aitken P, Caruso G & Alford F: Glucose utilization in type I (insulin-dependent) diabetes: evidence for a defect not reversible by acute elevations of insulin. Diabetologia 25: 331, 1983.

    Article  PubMed  CAS  Google Scholar 

  31. Terrettaz J & Jeanrenaud B: In vivo hepatic and peripheral insulin resistance in genetically obese (fa/fa) rats. Endocrinology 112: 1346, 1983.

    Article  PubMed  CAS  Google Scholar 

  32. Bar RS, Gorden P, Roth J & Siebert CW: Insulin receptors in patients with insulinomas: changes in receptor affinity and concentration. J. Clin. Endocrinol. Metab. 44: 1210, 1977.

    Article  PubMed  CAS  Google Scholar 

  33. Rizza RA, Haymond MW, Verdonk CA, Mandarino LJ, Miles JM, Service FJ & Gerich JE: Pathogenesis of hypoglycemia in insulinoma patients. Diabetes 30: 377, 1981.

    Article  PubMed  CAS  Google Scholar 

  34. Blackard WG, Guzelian PS & Small ME: Downregulation of insulin receptors in primary cultures of adult rat hepato- cytes in monolayer. Endocrinology 103: 548, 1978.

    Article  PubMed  CAS  Google Scholar 

  35. Amatruda JM, Newmeyer HW & Chang CL: Insulin-induced alterations in insulin binding and insulin action in primary cultures of rat hepatocytes. Diabetes 31: 145, 1982.

    Article  PubMed  CAS  Google Scholar 

  36. Martin MS & Pohl SL: Insulin-induced insulin resistance of a -aminoisobutyric acid transport in cultured human skin fibroblasts. J. Biol. Chem. 254: 9976, 1979.

    PubMed  CAS  Google Scholar 

  37. Proietto J, Nankervis A, Aitken P, Dudley FJ, Caruso G & Alford FP: Insulin resistance in cirrhosis: evidence for a post-receptor defect. Clin. Endocrinol. 21: 67 7, 1984.

    Google Scholar 

  38. Harewood MS, Proietto J, Dudley F & Alford FP: Insulin action and cirrhosis: insulin binding and lipogenesis in isolated adipocytes. Metabolism 31: 1241, 1982.

    Article  PubMed  CAS  Google Scholar 

  39. Kolterman OG, Insel J, Saekow M & Olefsky JM: Mechanisms of insulin resistance in human obesity. J. Clin. Invest. 65: 1272, 1980.

    Article  PubMed  CAS  Google Scholar 

  40. Mandarino L, Baker B, Rizza R, Genest J & Gerich J: Infusion of insulin impairs human adipocyte glucose metabolism in vitro without decreasing adipocyte insulin receptor binding. Diabetologia 27: 358, 1984.

    Article  PubMed  CAS  Google Scholar 

  41. Krupp M & Lane MD: On the mechanism of ligand-induced downregulation of insulin receptor level in the liver cell. J. Biol. Chem. 256: 1689, 1981.

    PubMed  CAS  Google Scholar 

  42. Crettaz M, Prentki M, Zaninetti D & Jeanrenaud B: Insulin- resistance in soleus muscle from obese Zucker rats. Biochem. J. 186: 525, 1980.

    PubMed  CAS  Google Scholar 

  43. Caro JF & Amatruda JM: Insulin receptors in hepatocytes: postreceptor events mediate downregulation. Science 210: 1029, 1980.

    Article  PubMed  CAS  Google Scholar 

  44. Doberne L, Greenfield MS, Schulz B & Reaven GM: Enhanced glucose utilization during prolonged glucose clamp studies. Diabetes 30: 829, 1981.

    PubMed  CAS  Google Scholar 

  45. Horton ES, Wardzala L, Hirshman M, Pofcher E & Horton ED: Chronic hyperinsulinemia increases insulin binding and insulin-stimulated glucose transport and metabolism in rat adipose cells without altering insulin sensitivity. Diabetes 32: 25A, 1983 (abstract).

    Google Scholar 

  46. Trimble ER, Weir GC, Gjinovci A, Assimacopoulos-Jeannet F, Benzi R & Renold AE: Increased insulin responsiveness in vivo and in vitro consequent to induced hyperinsuline- mia in the rat. Diabetes 33: 444, 1984.

    Article  PubMed  CAS  Google Scholar 

  47. Guerre-Millo M, Lavau M, Home JS and Wardzala LJ: Proposed mechanism for increased insulin-mediated glucose transport in adipose cells from young, obese Zucker rats. J. Biol. Chem. 260: 2197, 1985.

    PubMed  CAS  Google Scholar 

  48. Stout RW: The role of insulin in atherosclerosis in diabetics and nondiabetics. Diabetes 30 (Suppl. 2 ): 54, 1981.

    PubMed  CAS  Google Scholar 

  49. Susa JB, Neave C, Sehgal P, Singer DB, Zeller WP & Schwartz R: Chronic hyperinsulinemia in the fetal rhesus monkey. Diabetes 33: 656, 1984.

    Article  PubMed  CAS  Google Scholar 

  50. Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK & Zingg W: An artificial endocrine pancreas. Diabetes 23: 389, 1974.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Martinus Nijhoff Publishers, Dordrecht

About this chapter

Cite this chapter

Trimble, E.R. (1986). Hyperinsulinaemia. In: Radder, J.K., Lemkes, H.H.P.J., Krans, H.M.J. (eds) Pathogenesis and Treatment of Diabetes Mellitus. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4301-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-4301-8_14

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8411-6

  • Online ISBN: 978-94-009-4301-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics